In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Good afternoon, and welcome to the Alexandria Real Estate Equities fourth-quarter and year end 2024 conference call. (Operator Instructions) Please note this event is being recorded. I would now like ...

As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...

According to the Dickerson’s Pharmacy mission, they are “Saving patients time and money and cherishing friendships in Bladen ...

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...